Neurobo Pharmaceuticals Inc (NRBO)

$2.36 +0.01 (0.43%)
Market Cap 20.33M
Revenue (ttm) 0.00
Net Income (ttm) -12.47M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio 0.00
Volume 13,000
Avg Vol 45,138
Day's Range N/A - N/A
Shares Out 8.62M
Stochastic %K 50%
Beta -0.26
Analysts Strong Sell
Price Target $26.67
Latest News on NRBO
No data available.